TED website is eForms-ready since 2.11.2022. Search changed: please adapt your predefined expert queries. Discover the changes in the site news and in the updated Help Pages

Services - 410635-2021

13/08/2021    S156

Belgium-Brussels: Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU

2021/S 156-410635

Prior information notice

This notice is for prior information only

Services

Legal Basis:
Regulation (EU, Euratom) No 2018/1046

Section I: Contracting authority

I.1)Name and addresses
Official name: European Health and Digital Executive Agency (HaDEA), HADEA.A - Health and Food
Postal address: COV2, Place Charles Rogier 16
Town: Brussels
NUTS code: BE100 Arr. de Bruxelles-Capitale / Arr. Brussel-Hoofdstad
Postal code: B-1210
Country: Belgium
E-mail: hadea-eu4h-tenders@ec.europa.eu
Internet address(es):
Main address: https://hadea.ec.europa.eu
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://etendering.ted.europa.eu/cft/cft-display.html?cftId=9159
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
European institution/agency or international organisation
I.5)Main activity
General public services

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU

Reference number: HADEA/2021/OP/0009-PIN
II.1.2)Main CPV code
73000000 Research and development services and related consultancy services
II.1.3)Type of contract
Services
II.1.4)Short description:

Service contract encompassing the feasibility assessment, the design and prototype development of an interactive platform mapping the production capacity and supply of COVID-19 therapeutics in the EU including products in research and development phases. Such therapeutics can include ICU medicines, heparin, dexamethasone and antibiotics, in vitro diagnostics devices/companion diagnostics.

II.1.5)Estimated total value
Value excluding VAT: 5 000 000.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.2)Additional CPV code(s)
73000000 Research and development services and related consultancy services
II.2.3)Place of performance
NUTS code: BE100 Arr. de Bruxelles-Capitale / Arr. Brussel-Hoofdstad
Main site or place of performance:

COV2, Place Charles Rogier 16, B-1210 Brussels, BELGIUM.

II.2.4)Description of the procurement:

Feasibility study, design and prototype development for a mapping platform on COVID-19 therapeutics in the EU.

II.2.14)Additional information

Please consult the procurement documents available at the address indicated in section I.3).

II.3)Estimated date of publication of contract notice:
27/08/2021

Section IV: Procedure

IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no

Section VI: Complementary information

VI.3)Additional information:

Please consult the procurement documents available at the address indicated in section I.3).

VI.5)Date of dispatch of this notice:
06/08/2021